Cases & Deals

  • Home
  • Practices
  • Alizé Pharma enters into license agreement with EUSA Pharma on orphan drug

Share

Alizé Pharma enters into license agreement with EUSA Pharma on orphan drug

March 2008

Client(s) Alizé Pharma

Representation of Alizé Pharma in the negotiation of a Product Acquisition and License Option Agreement with EUSA Pharma on an orphan drug and a Research and Development Agreement with Protein Expert for the development of that drug.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.